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Vladimir P. Zhdanov1,2Abstract
Viral infections occur at very different length and time scales
and include various processes, which can often be described
using the models developed and/or employed in colloid and
interface science. Bearing in mind the currently active COVID-
19, I discuss herein the models aimed at viral transmission via
respiratory droplets and the contact of virions with the epithe-
lium. In a more general context, I outline the models focused
on penetration of virions via the cellular membrane, initial
stage of viral genome replication, and formation of viral cap-
sids in cells. In addition, the models related to a new genera-
tion of drug delivery vehicles, for example, lipid nanoparticles
with size about 100–200 nm, are discussed as well. Despite
the high current interest in all these processes, their under-
standing is still limited, and this area is open for new theoretical
studies.
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The scope of the colloid and interface science (CIS) is
extremely wide. According to the current instruction for
authors of the Journal of CIS, for example, it includes (i)
colloidal materials and nanomaterials; (ii) soft colloidal
and self-assembly systems; (iii) adsorption, catalysis, and
electrochemistry; (iv) interfacial processes, capillarity,
andwetting; (v) biomaterials and nanomedicine; and (vi)
energy conversion and storage, and environmentalwww.sciencedirect.comtechnologies. Looking through this list, one can notice
that items (i)e(v) are related to biology in general and
virology and pharmaceutics in particular. Practically, this
means that the basic concepts, experimental techniques,
and theoretical models developed in CIS can often be
used in virology to scrutinize the elementary processes
occurring during transmission of viral infections and
function of viruses inside hosts and to optimize and/or
find the ways of fighting with viral infections.
Compared to CIS, the scope of virology might appear to
be much narrower at first sight. In fact, however, the
latter scope is very wide as well, because viral infections
occur at very different length and time scales and,
because of the diversity of viruses, include a multitude
of processes with complex mechanistic details [1].
Basically, viruses are biological nanoparticles (virions) of
spherical (with a diameter ranging typically from 60 to
200 nm) or other shapes. Their DNA or RNA genome is
protected by a protein capsid and sometimes also by a
lipid membrane envelope. At the coarse-grained level,
viral infection is reduced to transmission and intracel-
lular replication of virions. The ways of transmission are
diverse. The viral replication cycle includes virion
attachment to a host-cell lipid membrane, penetration,
uncoating and release of genome, genome replication,
viral protein synthesis, capsid assembly, and escape from
the host. The understanding of all these steps is still
rather limited.
Historically, CIS was always based on the general physi-
cochemical concepts and theoretical models. One of the
famous generic examples is Smoluchowski’s seminal
model of diffusion-limited coagulation of colloidal par-
ticles. Another famous example is the Derjaguine
LandaueVerweyeOverbeek theory of interaction be-
tween colloids. Both these approaches are widely used in
various fields of natural sciences already many decades.
Nowadays, CIS includes many other models, which can
be employed in biology in general and virology in
particular. Some of these recently proposed models are
discussed below partially with emphasis on the currently
active coronavirus disease 2019 (COVID-19).Viral transmission
At the lumped level, the viral transmission occurs hori-
zontally from host to host or vertically from oneCurrent Opinion in Colloid & Interface Science 2021, 53:101450
Figure 1
Typical kinetics of evaporation of water from a respiratory droplet. Square
of the droplet radius is shown as a function of time for droplets with
R(0) = 0.5 mm and dry air (cN = 0). Two curves correspond to the situa-
tions with no and 20 virions, respectively. The virion size (diameter) is
100 nm. The results were obtained using Eq. (2) with B = 2 [5].
2 Hot Topic: COVID-19generation of hosts to the next [1]. More specifically, the
human viruses are transmitted via (i) disruptions of the
skin, (ii) mucosal membranes of the eye and genitouri-
nary tract, (iii) alimentary canal, and (iv) respiratory
tract (this is probably the most frequent channel of virus
infection) [1]. In the coarse-grained models aimed at
the kinetics of viral infection at the level of the sus-
ceptible and infected host populations, the transmission
is usually described by using the phenomenological
mean-field kinetic equations with corresponding rate
constants [2,3]. Physicochemical models of the trans-
mission are still lacking except those focused on the
pathway (iv) occurring via respiratory droplets gener-
ated during sneezing, coughing, and talking. This
channel is inherent to viruses, such as influenza and
COVID-19, and discussed in more detail in the
following paragraphs.
Respiratory droplets are formed of saliva produced and
secreted by salivary glands and containing, just after
secretion, primarily water (x99%) in combination with
nonvolatile matter (x1%) including sodium, potassium,
calcium, magnesium, bicarbonate, phosphates, immu-
noglobulins, proteins, enzymes, mucins, and nitroge-
nous products, such as urea and ammonia [4,5]. The
fraction of nonvolatile matter in droplets carrying virions
can be somewhat higher, up to x5% [6]. The size of
droplets is often 0.1e20 mm but may be larger [5]. For
comparison, spherically shaped lipid-membrane-
enveloped COVID-19 virions are x100 nm in diam-
eter [7]. The scale of the COVID-19 viral load in saliva
isw107 copies per ml but may be up tow109 copies per
ml [8]. For the droplets with the aforementioned size,
the corresponding formally calculated number of virions
is ≪1. This means that often droplets do not contain
virions, and only some of them contain one virion [6].
The distribution of virions in droplets is, however, ex-
pected to be far from Poissonian, and some of the
droplets, especially large ones, may contain many virions
[9].
In air, the coefficient of droplet diffusion and the ve-










where R, r, and m are the droplet radius, density, and mass
(m = 4prR3/3), respectively, and h is the air viscosity. To
use these equations, one should take into account that the
water vapor in the air is often below saturation, and
accordingly the droplet size decreases because of evapora-
tion of water. This process is limited by the diffusion of
water vapor from the dropleteair interface and to some
extent by convection of air near a droplet. For the sizes
typical for respiratory droplets, the local convection is
usually of minor importance (e.g. Ref. [10]), theCurrent Opinion in Colloid & Interface Science 2021, 53:101450evaporation rate calculated per unit area of the dropleteair
interface increases with decreasing the droplet size, and
the whole evaporation process is fairly fast. In relation to
COVID-19, it has recently been confirmed in a few theo-
retical studies (e.g. Refs. [5,10e12]) using the corre-
sponding textbook models (e.g. Ref. [13]).
At the simplest mean-field level with respect to the
interaction of water and nonvolatile matter, the
evaporation-related and diffusion-limited decrease of









where c and x are the volume fractions of water and
nonvolatile matter in their mixture, respectively, B > 0 is
the parameter taking the interaction between water and
nonvolatile matter into account, and
te ¼ R
2ð0Þ
2v+Dðcs  cNÞ (3)
is the evaporation time scale (v◦ is volume of a water
molecule, D* is the coefficient of diffusion of water in the
gas phase, and cs and cN are the concentration of water
molecules near and far from the interface, respectively).
In general, Eq. (2) should be complemented by the
equation describing the evaporation-related decrease of
the droplet temperature and the corresponding decrease
of cs. This effect is important but not dramatic. For
illustration of the shape of the evaporation kinetics and
estimates of the upper value of the evaporation time
scale, it can be neglected. In this approximation, Eq. (2)www.sciencedirect.com
Virology and colloid and interface science Zhdanov 3can be integrated alone (Figure 1). The corresponding
kinetics can be divided into two stages. During the main
stage, the nonvolatile matter can be neglected, that is,
one can set c = 1 and x = 0, and Eq. (2) results in the
following conventional R2 law:
R2 ¼ R2ð0Þð1 t = tevÞ: (4)
The late stage corresponds to appreciable fraction of the
nonvolatile matter in a droplet.
The heat transfer from a droplet to air is described by the
equation, which is mathematically similar to the
diffusion equation. In general, the joint solution of these
equations is complicated by the exponential dependence
of cs on temperature. In the case of respiratory droplets,
the variation of temperature is, however, modest, the
dependence of cs on temperature can be linearized, and
the main stage of the kinetics can be described analyti-
cally [10]. In particular, the R2 law remains to be valid
[10e12]. At a relative humidity of 0.5, the corresponding
evaporation time scale for 1-, 5-, and 10-mm-sized drop-
lets is 0.048, 0.12, and 0.48 s, respectively [10].
If the air is stagnant and the size of droplets is constant,
their average gravity-induced drift shift and squared
diffusion-related displacement are given as follows:
Dz ¼ mgDtkBT and Dx2þ Dy2 ¼ 4Dt: (5)










For the main stage of evaporation with the R2 law, the
integrals in these expressions can easily be calculated
analytically. According to these expressions, the drift
and diffusion-related displacement of respiratory drop-
lets with typical sizes are rather slow [5,10]. Practically,
this means that the respiratory droplets move often with
air via convection. Various aspects of this motion have
recently been analyzed, for example, in Refs. [14e18].
Eventually, the respiratory droplets attach to surfaces.
Evaporation of water from droplets located at a surface is
described in Refs. [19e21].
In Northern countries, the outdoor air temperature can
be below 0 C. Under such conditions, the temperature
inside respiratory droplets rapidly (compared to evapo-
ration) drops below 0 C as well, droplets becomewww.sciencedirect.comfrozen, and then the evaporation is very slow and the
motion of frozen droplets is controlled primarily by the
gravity (with m = const and D = const) and convection.
Taken together, the available models form a good basis
for understanding the behavior of respiratory droplets
in the air. Additional efforts in this area can be
focused, for example, on scrutinizing the specific role
of different components of nonvolatile matter on
evaporation of water from droplets. In this context,
one can notice that the saliva appears to be structured
as a highly woven network interconnected by threads
[4], and to what extent this feature is important for
the transmission of virions is not clear. The available
theoretical and experimental data appear to indicate
that after evaporation of water from droplets, the
nonvolatile matter in its condensed form is protective
or at least not too destructive with respect to COVID-
19 virions [21].At the epithelium and in the body
The coarse-grained kinetic models of viral infection are
usually temporal and operate with populations of virions
and cells inside an infected person [22]. The spatio-
temporal models are also available [3,22], but, as already
noticed in the Introduction, the mechanistic details of
virion transport inside the host are not described
explicitly there. In fact, the corresponding full-scale
mechanistic models are now often lacking. Although
such details can, in principle, be experimentally ob-
tained in vivo using optical single-virus tracking tech-
niques, the available studies of this category are limited
to investigations of the infection mechanism of viruses
in cultured cells [23].
In the case of infections transmitted via air (discussed in
the previous section), virions first reach the epithelium.
More specifically, virions penetrate a gel-like mobile
mucus layer and a brush-like periciliary layer located
above the epithelium cells, contact these cells, and then
start the viral cycles [24]. The complicating factor here
is that the upper gel layer is moving along the cells. The
scale of the corresponding velocity is 40 mm/s [25]. The
simplest expression for the 2D distribution (concen-
tration) of virions thereafter delivery by a respiratory
droplet at t = 0 is as follows (cf. Eq (42) in Ref. [5]):




 jr  vtj
2
r2+ þ 4Dt
 ðkp þ kdþ kÞt

; (6)
where Nv is the initial number of virions, r◦ is the length
scale characterizing the initial virion distribution, v (or v
below) is the gel velocity, D is the effective coefficient of
virion diffusion in the lumped layer including the mucusCurrent Opinion in Colloid & Interface Science 2021, 53:101450
4 Hot Topic: COVID-19and periciliary layers, and kp, kd, and k* are the virion cell-
membrane penetration, detachment, and degradation rate
constants, respectively. This expression allows one to
classify various possible regimes of the evolution of the
initial virion distribution depending on the ratio between
the timescales of conversion, tc = 1/(kp þ kd þ k*), flow-
mediated transport, tc = L/v, and diffusion, td = L
2/4D
(L is the cell size). More detailed models have recently
been proposed in Refs. [25,26]. The spatial distribution of
the velocity has been analyzed in Ref. [27].
The spreading of virions in human bodies occurs
through blood and lymph vessels and tissue. In the case
of COVID-19, for example, the electron microscopy
shows virions in endothelial cells across vascular beds of
different organs in a series of patients [28]. Theoreti-
cally, the transport of virions in blood and lymph vessels
can be described by analogy with that of nanoparticles
(see the section ‘New trends in drug delivery’).Penetration through a lipid membrane
In Eq. (6), the interaction of virions with the cell
membrane is described at the simplest level by intro-
ducing the effective penetration rate constant, kp. In
reality, it occurs in a few steps and can be described in
more detail. First, a virion associate with a single re-
ceptor. This process is expected to be limited by virion
diffusion. If the corresponding diffusion coefficient, D
[Eq. (1)], is constant and the ligandereceptor tethers
are flexible, the association rate constant can be repre-
sented as follows [29]:
kas ¼ 4rD ¼ 4ð2lRÞ1=2D; (7)
where r = (2lR)1/2 is the radius of the effective virion-
membrane contact area (R is the virion radius, and l is
the tether length). A more accurate expression for this rate
constant can be obtained taking the slowdown of diffusion
near the interface into account [30],
kas ¼ 5:9lD; (8)
where D is the diffusion coefficient far from the interface
[Eq. (1)]. The subsequent formation of tethers occurs via
diffusion of receptors to the virion-cell-membrane contact
region as, for example, described in Ref. [31]. This process
is accompanied by the membrane bending and then by the
virion entry into the cell occurring usually via endocytosis
or, in the case of enveloped viruses, via fusion of the virion
envelope with the cell membrane (reviewed in
Refs. [32,33]). Besides multivalent ligandereceptor inter-
action and membrane bending, both these processes
depend also on the deformation of actin filaments forming
the cytoskeleton of the host cell. The models focused on
various aspects of viral endocytosis are now numerous (e.g.
recent articles [34e38] and references therein).Current Opinion in Colloid & Interface Science 2021, 53:101450A virion linked with the lipid membrane by a few tethers
can diffuse. This process can be described by various
models implying (i) collective diffusion in the 2D lipid
fluid [as in the 3D Stokes case (2)] with the logarith-
mically weak dependence on the number of tethers
[39], (ii) nearly independent diffusion of tethers with
the diffusion coefficient inversely proportional to the
number of tethers [39], or (iii) spider-like diffusion
including rupture and formation of tethers [40].Intracellular viral kinetics
After penetration into the host cells, virions induce host-
mediated replication of their RNA or DNA, production
of the corresponding proteins, assembly of new virions,
and their release to the extracellular environment.
Although now some of the intracellular virus-related
processes can be directly tracked in cells [41], the un-
derstanding of intracellular viral kinetics is still limited.
Theoretically, the interplay of the viral replication and
the host gene expression is customarily described using
a set of temporal mean-field kinetic equations for the
intracellular population of various species (reviewed in
Ref. [42]). The corresponding models are often generic.
The models focused on specific viruses are usually
coarse-grained (e.g. Refs. [43,44]; for COVID-19, such
models are lacking).
The use of the generic models can be illustrated by
referring to the discussion concerning the minimal
number of virions needed for the initiation of infection
in a host (e.g. Refs. [41,45]). In principle, the infection
of one cell by one virion may be sufficient, that is, this
number can be as small as one (this is the so-called in-
dependent action hypothesis). There are, however,
experimental indications that one virion is not sufficient
[45]. One of the general ideas here is that in the case of
segmented viruses, such as influenza A, a few virions are
needed to compensate for intrinsic genetic and/or
structural virion defects. The corresponding kinetic
model is proposed in Ref. [46].
Another general idea is that a few virions are needed to
overcome host infection barriers that limit early viral
proliferation, for example, replication [5,45]. More
explicitly, this means that (i) in the limit of small
number of virions in a cell, the degradation of virions
should dominate so that the virion population decreases
exponentially provided there is no supply of virions or
first grows but then decreases provided the supply of
virions is slow and decreases with increasing time down
to extinction, and (ii) with increasing number of virions
in a cell, their replication should become more efficient
due to positive feedback and/or the degradation of vi-
rions should become less efficient due to negative
feedback [5]. Under such conditions, the stable steadywww.sciencedirect.com
Virology and colloid and interface science Zhdanov 5state corresponds to the extinction of virions. With
increasing the number of virions, there is an unstable
steady state with transition either back to extinction or
to the virion-population growth resulting in the full-
scale cell infection. To reach the latter regime, the
current number of virions in a cell should be sufficiently
large. The corresponding number of the supplied virions
should exceed this number and accordingly should be
large as well. Mathematically, this can be illustrated
using the following simplest coarse-grained equation for
the intracellular viral genome population [5]:
dNG=dt ¼ krNG  kdNG þ wðtÞ; (9)
where kr and kd are the replication and degradation rate
constants, respectively, and w(t) is the supply rate. The
presence of feedback means that these rate constants
should depend on NG. The positive feedback in kr has
already been described [5]. The role of the negative
feedback in kd can be shown (Figure 2) using the corre-
sponding Hill expression:
kd ¼ k+d þ kdKm
ðKm þNmGÞ; (10)
where k+d , k

d, K, and m are the corresponding parameters.
(The Hill expression is usually used to describe the regu-
lation of gene transcription via protein attachment to the
regulatory sites [47]. Here, this expression is used to mimic
the feedback in a lumped way without specification of the
mechanistic details.)Intracellular virus-related processes
In the mean-field kinetic models mentioned in the
previous section, the elementary steps are character-
ized by the corresponding rate constants. The mech-
anistic details of these steps are of high interest. TheFigure 2
Graphical solution of Eq. (9) with negative feedback for viral genome
degradation [Eq. (10) with k+d=kr ¼ 0:2, kd=kr ¼ 2, K = 10, and m = 4]
and no feedback for replication under steady-state conditions [with
w(t) = 0]. The virion birth and degradation rates are normalized to kr.
www.sciencedirect.comexperimental information concerning the virus-related
steps is in fact lacking. On the theoretical side, the
mechanisms of the key virus-related steps can, in
principle, be described using or by analogy with
already available numerous models of the gene
expression including transcription of DNA into RNA
and RNA translation to proteins (for such models, see,
e.g., Refs. [48,49] and references therein). The
corresponding theory focused on viruses is now in its
initial phase (reviewed in detail in Ref. [50]). One of
the processes that has attracted appreciable attention
of experimentalists and theoreticians is viral capsid
formation (reviewed in Ref. [51]). The corresponding
kinetic models are often oriented to academic studies
and imply the assembly at steady-state conditions.
The model aimed at the assembly in vivo under tran-
sient conditions was proposed in Ref. [52].New trends in drug delivery
CIS is an essential part of the scientific background of
pharmaceutics. For example, all disperse systems used
in pharmaceutical formulations such as suspensions,
emulsions, gels, and ointments include colloid and
interface phenomena and their development and opti-
mization are partly based on the CIS approaches [53].
The development of a new generation of drugs is widely
expected to be based on advances in CIS and nano-
science. In virology, this implies the use of (i)
nanomaterial-enhanced viral replication inhibitors
suppressing the production of new virions, (ii) virus-
binding nanoparticles including viral membrane in-
hibitors that can disrupt membrane-enveloped virus
particles, (iii) cell membrane decoys binding to virions,
and (iv) biomimetic nanoparticle vaccines [54]. In
the context of COVID-19, nanoscale vaccine-delivery
systems are expected to play a paramount role [55]. For
example, two vaccines developed and proved recently
by BioNtech and Pfizer and Cambridge-based biotech
company include lipid nanoparticles as carriers [56,57].
Nanocarriers of this and other types are now intensively
studied in the context of various medical applications
[58,59].
The models already developed in CIS or with suitable
modifications can be used to rationalize the biophysics
related to aforementioned approaches (i)e(iv). In the
context of virus-binding nanoparticles (item (ii); see
e.g., Ref. [60]), for example, the 3D association of
nanoparticles with virions is often limited by diffusion
and can be described using the conventional Smolu-
chowski rate constant, which is as follows:
kax4pRD; (11)
where R ¼ R1 þ R2 is the contact radius or, more specif-
ically, the sum of the two nanoparticle radii, and D is the
sum of the diffusion coefficients of the two nanoparticles.Current Opinion in Colloid & Interface Science 2021, 53:101450
Figure 3
Drug concentration profiles around a cylindrically shaped blood vessel
according to Eq. (15) with ar = 0.03, 0.1, 0.3, and 1.
6 Hot Topic: COVID-19This expression does not take the slowdown of diffusion
into account, but this effect is not dramatic in the 3D case





where Ib > 0 and l are the ligand-receptor-pair binding
energy and length, respectively, and n is the maximum
number of ligandereceptor pairs in the contact area with
radius r = [2lR1R2/(R1 þ R2)] [cf. with r in (7)].
In the context of cell membrane decoys [item (iii)], one
is expected to estimate the relative rates of ligand-
receptor-pair-mediated association and dissociation of
various nanoparticles or their attachment and detach-
ment to membrane receptors. The very initial attach-
ment to membrane receptors has already been discussed
briefly [Eqs. (7) and (8)]. The corresponding multiva-
lent aspects of attachment were scrutinized in
Refs. [34,62,63].
In all these areas [items (i)-(iii)], the needed selectivity
of the species with respect to interaction with virions
should be determined under real conditions. Such data
are now lacking. This aspect can partly be claried using
the CIS-based models.
An important and still poorly understood problem is how
to describe drug or vaccine release from nanoparticles
[64,65]. The models developed for macroscopic pellets
and microcapsules and including conventional Fick’s
drug diffusion and/or pellet dissolution (see, e.g.
Refs. [66,67]) are here not directly applicable because
the corresponding mechanistic aspects are different. For
example, the delivery of lipid nanoparticles into cells is
often followed by their trapping by endosomes, and in
this case, the drug or vaccine release is believed to occur
through fusion of the lipoplex with the endosome
membrane or via transient pores in the endosome
membrane [64]. The corresponding fusion- and
transient-pore models are conceptual, and their scrutiny
is lacking.
Concerning the intracellular kinetics after mRNA de-
livery and release, I can mention the models presented
in Refs. [68,69].
The drug efficiency depends on its distribution in a
body after injection. This distribution is often formed
via drug convective transport in blood and lymph vessels
with subsequent penetration into tissue and diffusion
there. The corresponding details are central for opti-
mization of the drug function (in the case of solid
tumors, e.g., only w1% of nanoparticles are now suc-
cessfully delivered to the target [70], and one of the
reasons why this is the case is that nanoparticles oftenCurrent Opinion in Colloid & Interface Science 2021, 53:101450reach and accumulate in lymph nodes and result in
toxicity [71]) and also to understand, for example, why
drugs tested in mice may fail in human (one of the
reasons is the difference in the length and time scales,
and this aspect can be clarified using models). This
subject is complex due to the abundance of related
species and heterogeneity of the systems with a broad
distribution of the length and time scales (especially in
the case of tumors [72]). The related models including
convective and diffusion drug transport and focused
often on cancer are numerous and contain many in-
gredients (see, e.g., recent articles concerning conven-
tional drug delivery [73,74] and delivery by drug-loaded
nanocarriers [75,76]). Despite this progress, there is still
much room for their improvement.
The type of the model ingredients used in this area can
be illustrated by analyzing a generic case of diffusion-
controlled drug distribution in the interstitial space
around a single cylindrically shaped blood vessel. The














where r is the radial coordinate, D is the diffusion coeffi-
cient, and k is the rate constant associated with the drug
consumption by tissue cells. The boundary conditions for
this equation near the vessel (at r= r, where r is the vessel
radius) can be set as c(r) = c◦, where c◦ is the corre-
sponding concentration (it can be equal to that in the
vessel if the drug penetration via the vessel wall is rapid or
related with that in the vessel, e.g., by analogy with the
Starling equation otherwise). The second no-flux boundary
condition, vc/vr = 0, can be imposed r = R, where R is the
distance roughly equal to one half of that up to the adjacent
vessels. Physically, the latter no-flux condition separateswww.sciencedirect.com
Virology and colloid and interface science Zhdanov 7the regions associated with different vessels. Taking into
account that on the time scale of the drug action, the local
drug diffusion is rapid, Eq. (13) can then be solved in the
steady-state approximation (by setting vc/vt = 0):
cðrÞ ¼ K0ðarÞI1ðaRÞ þ I0ðarÞK1ðaRÞ
K0ðarÞI1ðaRÞ þ I0ðarÞK1ðaRÞ c+; (14)
where a h (k/D)1/2, and K0, I0, K1 and I1 are the modified
Bessel functions. If the drug consumption is efficient so
that aR[ 1, I0 in Eq. (14) can be neglected, and we have
cðrÞ ¼ K0ðarÞ
K0ðarÞ c+: (15)
This expression predicts that in the practically inter-
esting case with ar ≪ 1, the corresponding concentra-
tion profiles are far from exponential (Figure 3). In
addition, the drug influx per unit vessel length is weakly
dependent on the vessel radius [this follows from the
asymptotic expression for K0(ar)] or, in other words, the
rate of the drug delivery per unit volume of tissue is
roughly inversely proportional to the tissue volume per
unit vessel length. The model also shows that even in
one of the simplest situations the corresponding equa-
tions are relatively complex.Conclusion
In this brief review, I have outlined various physico-
chemical models used in virology with a slight bias on
those related to COVID-19. Such models are extremely
diverse, and from this perspective, the review is far from
complete partly because the choice was primarily
limited to those linked somehow with CIS. The corre-
sponding links have been indicated explicitly or implied.
In general, the interplay between CIS and biology is
natural and fruitful. In fact, the focus of studies in CIS is
now shifting to different areas of biology, and virology is
just one of the examples.Declaration of competing interest
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